Technical Analysis for ACHV - Achieve Life Sciences, Inc.

Grade Last Price % Change Price Change
B 4.71 0.64% 0.03
ACHV closed up 0.64 percent on Friday, November 1, 2024, on 55 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It was able to find support at its 50 day moving average. It was able to bounce off of its 200 day moving average, an important long-term support line. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Nov 7
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Down

Date Alert Name Type % Chg
200 DMA Support Bullish 0.00%
50 DMA Support Bullish 0.00%
NR7 Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Oversold Stochastic Weakness 0.00%
MACD Bearish Centerline Cross Bearish 0.64%
200 DMA Support Bullish 0.64%
50 DMA Support Bullish 0.64%
Lower Bollinger Band Touch Weakness 0.64%

   Recent Intraday Alerts

Alert Time
200 DMA Support about 19 hours ago
Possible NR7 about 19 hours ago
Possible Inside Day about 19 hours ago
50 DMA Support about 22 hours ago
200 DMA Resistance about 22 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Achieve Life Sciences, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. It is developing Apatorsen to block the production of heat shock protein 27, a cell-survival protein expressed in various types of cancers, including bladder, prostate, breast, pancreatic, and non-small cell lung cancer. The company is headquartered in Bothell, Washington.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Breast Cancer Prostate Cancer Non Small Cell Lung Cancer Treatment Of Breast Cancer Small Cell Lung Cancer Oncolytics Biotech Apatorsen

Is ACHV a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 5.98
52 Week Low 3.03
Average Volume 96,484
200-Day Moving Average 4.67
50-Day Moving Average 4.67
20-Day Moving Average 4.92
10-Day Moving Average 4.77
Average True Range 0.17
RSI (14) 45.36
ADX 18.58
+DI 17.29
-DI 23.19
Chandelier Exit (Long, 3 ATRs) 4.76
Chandelier Exit (Short, 3 ATRs) 5.12
Upper Bollinger Bands 5.26
Lower Bollinger Band 4.58
Percent B (%b) 0.2
BandWidth 13.87
MACD Line -0.01
MACD Signal Line 0.04
MACD Histogram -0.046
Fundamentals Value
Market Cap 99.69 Million
Num Shares 21.2 Million
EPS -2.02
Price-to-Earnings (P/E) Ratio -2.33
Price-to-Sales 0.00
Price-to-Book 23.59
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.82
Resistance 3 (R3) 4.80 4.76 4.80
Resistance 2 (R2) 4.76 4.73 4.76 4.79
Resistance 1 (R1) 4.73 4.71 4.75 4.75 4.79
Pivot Point 4.69 4.69 4.69 4.69 4.69
Support 1 (S1) 4.66 4.66 4.68 4.68 4.63
Support 2 (S2) 4.62 4.64 4.62 4.63
Support 3 (S3) 4.59 4.62 4.62
Support 4 (S4) 4.61